Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Jan Steffel, Rónán Collins, Matthias Antz, Pieter Cornu, Lien Desteghe, Karl Georg Hæusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldán, Nigel Rowell, Peter Sinnaeve, Thomas Vanassche, Tatjana Potpara, A. John Camm, Hein Heidbüchel, Professor Gregory Lip, Thomas Deneke, Nikolaos Dagres, Giuseppe Boriani, Tze-Fan Chao, Eue-Keun Choi, Mellanie True Hills, Itamar S Santos, Deirdre A. Lane, Dan Atar, Boyoung Joung, Oana Maria Cole, Mark Field (2021). 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. , 23(10), DOI: https://doi.org/10.1093/europace/euab065.
Article25 days agoLong-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
John W. Eikelboom, Jackie Bosch, Stuart J. Connolly, Jessica Tyrwitt, Keith A.A. Fox, Eva Muehlhofer, Christoph Neumann, Christoph Tasto, Shrikant I. Bangdiwala, Rafael Díaz, Marco Alings, Gilles R. Dagenais, Darryl P. Leong, Eva Lonn, Álvaro Avezum, Leopoldo Soares Piegas, Petr Widimský, Alexander Parkhomenko, Deepak L. Bhatt, Kelley R. Branch, Jeffrey L. Probstfield, Patricio López‐Jaramillo, Lars Rydén, Nana Pogosova, Katalin Keltai, Matyàs Keltai, Georg Ertl, Stefan Störk, Antonio L Dans, Fernando Laņas, Yan Liang, Jun Zhu, Christian Torp‐Pedersen, Aldo Maggioni, Patrick Commerford, Tomasz J. Guzik, Thomas Vanassche, Peter Verhamme, Martin O’Donnell, Andrew M. Tonkin, George Varigos, Dragoş Vinereanu, Camillo Felix, Jae‐Hyung Kim, Khairul Shafiq Ibrahim, Basil S. Lewis, Kaj Metsärinne, Victor Aboyans, Philippe Gabríel Steg, Masatsugu Hori, Ajay K. Kakkar, Sonia S. Anand, André Lamy, Mukul Sharma, Salim Yusuf (2022). Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. , 8(8), DOI: https://doi.org/10.1093/ehjcvp/pvac023.
Article24 days agoLow-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial
Thomas Vanassche, Peter Verhamme, Sonia S. Anand, Olga Shestakovska, Darryl P. Leong, Keith A.A. Fox, Deepak L. Bhatt, Álvaro Avezum, Marco Alings, Victor Aboyans, Aldo Maggioni, Petr Widimský, Eva Muehlhofer, Scott D. Berkowitz, Salim Yusuf, Stuart J. Connolly, John W. Eikelboom, Jackie Bosch (2021). Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial. , 8(5), DOI: https://doi.org/10.1093/ehjcvp/pvab050.
Article24 days agoEfficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial
Thomas Vanassche, Peter Verhamme, Darryl P. Leong, Deepak L. Bhatt, Olga Shestakovska, Aldo Maggioni, Keith A.A. Fox, Eva Muehlhofer, Stuart J. Connolly, Salim Yusuf, John W. Eikelboom, Jackie Bosch (2020). Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial. , 41(Supplement_2), DOI: https://doi.org/10.1093/ehjci/ehaa946.1449.
Article24 days agoRisk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial
Thomas Vanassche, Peter Verhamme, Sonia S. Anand, Olga Shestakovska, Keith A.A. Fox, Deepak L. Bhatt, Álvaro Avezum, Marco Alings, Victor Aboyans, Aldo Maggioni, Petr Widimský, Scott D. Berkowitz, Salim Yusuf, Stuart J. Connolly, John W. Eikelboom, Jackie Bosch (2019). Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial. , 27(3), DOI: https://doi.org/10.1177/2047487319882154.
Article24 days ago